162 related articles for article (PubMed ID: 12715763)
1. The estrogen and progestin dilemma: new advice, labeling guidelines.
Bren L
FDA Consum; 2003; 37(2):10-1. PubMed ID: 12715763
[No Abstract] [Full Text] [Related]
2. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
3. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
4. Combination hormone therapy tied to slight increase in breast cancer deaths.
Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
[No Abstract] [Full Text] [Related]
5. New information about hormone therapy and cardiovascular disease prevention in women.
Goldie MP
Int J Dent Hyg; 2007 Aug; 5(3):190-3. PubMed ID: 17615030
[No Abstract] [Full Text] [Related]
6. Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
[No Abstract] [Full Text] [Related]
7. Wayward sisters. Progestin siblings exert opposite effects on monkey hearts.
Beckman M
Sci Aging Knowledge Environ; 2004 Oct; 2004(41):nf91. PubMed ID: 15483332
[No Abstract] [Full Text] [Related]
8. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
9. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
[No Abstract] [Full Text] [Related]
10. Women's health. More questions about hormone replacement.
Couzin J; Enserink M
Science; 2002 Nov; 298(5595):942. PubMed ID: 12411676
[No Abstract] [Full Text] [Related]
11. Pfizer ordered to pay $103m over hormone drugs and breast cancer.
Tanne JH
BMJ; 2009 Nov; 339():b5085. PubMed ID: 19946002
[No Abstract] [Full Text] [Related]
12. A clinician's review of the WHI-related literature.
Speroff L
Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
[TBL] [Abstract][Full Text] [Related]
13. [Hormone replacement therapy in menopause].
Breckwoldt M
Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
[No Abstract] [Full Text] [Related]
14. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
Lippert TH; Mueck AO
MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
[No Abstract] [Full Text] [Related]
15. Postmenopausal hormones: where do we go from here?
Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
[No Abstract] [Full Text] [Related]
16. Hormone therapy's unanswered questions.
Harv Womens Health Watch; 2004 Jul; 11(11):1. PubMed ID: 15273055
[No Abstract] [Full Text] [Related]
17. NIH workshop tries to create consensus on HRT use.
Randal J
J Natl Cancer Inst; 2003 Jan; 95(1):9-11. PubMed ID: 12509392
[No Abstract] [Full Text] [Related]
18. Progesterone and Synthetic Progestin Controversies.
Gompel A; Plu-Bureau G
JAMA Oncol; 2015 Oct; 1(7):987. PubMed ID: 26448287
[No Abstract] [Full Text] [Related]
19. Progesterone and Synthetic Progestin Controversies.
Jordan VC; Maximov PY; Fan P
JAMA Oncol; 2015 Oct; 1(7):986-7. PubMed ID: 26448286
[No Abstract] [Full Text] [Related]
20. Progesterone and Synthetic Progestin Controversies--Reply.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Oct; 1(7):987-8. PubMed ID: 26448288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
